Articles
Bridging the gap

Bridging the gap

As joint working and cooperation move to replace push selling by pharma, Alan Naismith draws a tongue in cheek comparison with crumbling bridges and challenges the industry to engage more quickly in such initiatives. After the devastating floods in Cumbria in November an analogy about bridges may seem a little tasteless, but it is very apt. The bridge I refer to is the one formed by...

Articles
Joint working with the NHS: sleeping with the enemy?

Joint working with the NHS: sleeping with the enemy?

Dr. Paul Stuart-Kregor discusses the topic of joint working in the UK and takes a look at some of the challenges the commercial industry must overcome to embrace it. Much has been made of the changing nature of pharma’s customer base. No longer is the GP king or queen in the UK. Rather their medical practice is...

Articles
Why pharma struggles with social media

Why pharma struggles with social media

As the world of social media continues to explode in 2010, Dr. Andree Bates takes a look at why it has yet to make a major impact in pharma and what to do about it. Every man and his dog is talking about social media right now. Social media is the biggest revolution to have happened...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. FDA nominee Overton dodges questions on Trump influence
  2. Australia starts probe into AI infiltration of Medicare
  3. Lilly forges $3.35bn alliance with China's InnoCare
  4. Telix to buy radiopharma rival ITM for $1.65bn upfront
  5. Advocacy group pokes holes in Trump's MFN pricing claims

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more